| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/27/2011 | CN101214275B Compound red sage root extended release formulation and preparation thereof |
| 07/27/2011 | CN101199576B Medicament prescription for treating coronary heart disease |
| 07/27/2011 | CN101181445B Antihypertensive Chinese medicine |
| 07/26/2011 | US7985887 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/26/2011 | US7985760 Piperidinetriol derivatives as inhibitors of glycosyceramid synthase |
| 07/26/2011 | US7985563 HIFαprolyl hydroxylation assay |
| 07/26/2011 | US7985558 Methods for diagnosis of cardiovascular disease |
| 07/26/2011 | CA2644467C Alpha crystalline form of perindopril arginine salt, its preparation process, and the pharmaceutical compositions that contain it |
| 07/26/2011 | CA2502877C Metastable benzoxepine derivatives which can be used in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions comprising them and processes forthe preparation thereof |
| 07/26/2011 | CA2487976C Calcitonin gene related peptide receptor antagonists |
| 07/26/2011 | CA2484981C 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors |
| 07/26/2011 | CA2464333C Heteroindanes: a new class of potent cannabimimetic ligands |
| 07/26/2011 | CA2445344C Heterocyclic compound derivatives and medicines |
| 07/26/2011 | CA2427655C Use of alpha adrenergic receptor agonist to reduce a decrease in neurosensory retinal function following laser therapy for choroidal neovascularization |
| 07/26/2011 | CA2367787C Ligands for metabotropic glutamate receptors |
| 07/21/2011 | WO2011087776A1 Isoindolinone inhibitors of phosphatidylinositol 3-kinase |
| 07/21/2011 | WO2011087393A1 Composition of vegetal origin for inhaling the smoke generated upon the combustion thereof |
| 07/21/2011 | WO2011087066A1 Pharmaceutical for preventing or treating disorders accompanied by ocular angiogenesis and/or elevated ocular vascular permeability |
| 07/21/2011 | WO2011087051A1 Therapeutic agent for atherosclerosis comprising s1p2 receptor antagonist |
| 07/21/2011 | WO2011086306A1 5-oxo-5, 8-dihydropyrido [2, 3-d] pyrimidine derivatives as camkii kinase inhibitors for treating cardiovascular diseases |
| 07/21/2011 | WO2011086081A1 2,5-substituted oxazolopyrimidine derivatives |
| 07/21/2011 | WO2011086080A1 Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring |
| 07/21/2011 | WO2011086079A1 Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring |
| 07/21/2011 | WO2011086077A1 Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
| 07/21/2011 | WO2011086075A1 2,5,7-substituted oxazolopyrimidine derivatives |
| 07/21/2011 | WO2011085701A1 Stable protein kinase activators, preparation methods and uses thereof |
| 07/21/2011 | WO2011034580A3 Small peptide modulators of potassium channel trafficking |
| 07/21/2011 | WO2011029102A3 Cd117+cells and uses thereof |
| 07/21/2011 | WO2011027988A3 Novel polymorphic form of prasugrel-hydrogen sulfate |
| 07/21/2011 | WO2011026041A9 Sdf-1 delivery for treating ischemic tissue |
| 07/21/2011 | WO2011026015A3 Stabilized melanocortin ligands |
| 07/21/2011 | WO2011014611A3 Preparation of olmesartan medoxomil |
| 07/21/2011 | WO2011010084A3 Cyclosporin conjugates |
| 07/21/2011 | WO2010141879A3 Peptides for transport of therapeutics and their carriers in mouse models and humans |
| 07/21/2011 | WO2010071783A8 Thiazoles as cannabinoid receptor ligands |
| 07/21/2011 | US20110178294 Novel carboxylic acid derivatives, their preparation and use |
| 07/21/2011 | US20110178183 Use Of Polyether-Based And Vinyl Monomer-Based Copolymers As Binders For Dosing Forms Comprising Solid Active Ingredients |
| 07/21/2011 | US20110178168 Coumarin compounds for the treatment of cardiovascular diseases and a process for preparing the same |
| 07/21/2011 | US20110178165 Tetrahydrofuranyl sulfonamides and pharmaceutical compositions thereof |
| 07/21/2011 | US20110178146 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 07/21/2011 | US20110178137 Diaryl urea for treating heart failure |
| 07/21/2011 | US20110178133 Calcium receptor modulating agents |
| 07/21/2011 | US20110178130 MACROCYCLIC UREA AND SULFAMIDE DERIVATIVES AS INHIBITORS OF TAFIa |
| 07/21/2011 | US20110178111 Long-term treatment of symptomatic heart failure |
| 07/21/2011 | US20110178105 Clinical benefits of eicosapentaenoic acid in humans |
| 07/21/2011 | US20110178101 Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents |
| 07/21/2011 | US20110178096 Octahydropentalene compounds as chemokine receptor antagonists |
| 07/21/2011 | US20110178090 Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof |
| 07/21/2011 | US20110178082 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/21/2011 | US20110178081 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/21/2011 | US20110178079 Guanidine compounds as anesthetics and for treatment of nervous system disorders |
| 07/21/2011 | US20110178075 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 07/21/2011 | US20110178066 Hydroxypiperidine derivatives and uses thereof |
| 07/21/2011 | US20110178063 Benzpyrazol derivatives as inhibitors of pi3 kinases |
| 07/21/2011 | US20110178061 Heterocyclic derivatives for modulation of calcium channels |
| 07/21/2011 | US20110178059 1,3-oxazolidin -2-one derivatives useful as cetp inhibitors |
| 07/21/2011 | US20110178057 Heterocyclic compound and use thereof |
| 07/21/2011 | US20110178054 Heterocyclic GPCR Agonists |
| 07/21/2011 | US20110178039 Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them |
| 07/21/2011 | US20110178038 Indole Antiviral Compositions And Methods |
| 07/21/2011 | US20110178023 Use Of SCO-Spondin Peptides For Inhibiting Or Preventing Neuronal Apoptosis Mediated By Cell Death Receptor Ligands |
| 07/21/2011 | US20110178017 Modified vasoactive intestinal peptides |
| 07/21/2011 | US20110178014 Prevention and treatment of cardiac arrhythmias |
| 07/21/2011 | US20110178012 Use of human chorionic gonadotropin orally for the treatment of overweight (obesity) associated with high blood tension, non-insulin-dependant diabetes, hypercholesterolemia, dyslipidemias and lipodystrophy. |
| 07/21/2011 | US20110178006 Method for administering glp-1 molecules |
| 07/21/2011 | US20110178000 Apoptotically Active Peptides |
| 07/21/2011 | US20110177998 Bioactive peptides and methods of using same |
| 07/21/2011 | US20110177595 Multipotent Adult Stem Cells, Sources Thereof, Methods of Obtaining and Maintaining Same, Methods of Differentiation Thereof, Methods of Use Thereof and Cells Derived Thereof |
| 07/21/2011 | US20110177179 Preparation of botanical extracts containing absorbable components using pharmaceutical platform technology |
| 07/21/2011 | US20110177167 Hydrophilic/Lipophilic Polymeric Matrix Dosage Formulation |
| 07/21/2011 | US20110177166 Galenical Formulation Comprising Aliskiren and Process for its Preparation by Melt Extrusion Granulation |
| 07/21/2011 | US20110177160 Amino acid lipids and uses thereof |
| 07/21/2011 | US20110177159 Custom-formulated phospholipid microbubbles and methods and uses thereof |
| 07/21/2011 | US20110177156 Sterol-Modified Amphiphilic Lipids |
| 07/21/2011 | US20110177152 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease |
| 07/21/2011 | US20110177138 Alcohol-resistant sustained-release oral pharmaceutical form based on microgranules |
| 07/21/2011 | US20110177113 Use of antrodia camphorata for treating diseases |
| 07/21/2011 | US20110177106 Novel Therapeutic Methods for Treating Inflammation and Immune System Disorders |
| 07/21/2011 | US20110177105 Novel Selective Inhibitors of Ubiquitin Specific Protease 7, the Pharmaceutical Compositions Thereof and Their Therapeutic Applications |
| 07/21/2011 | US20110177097 Methods for modulating expression of creb |
| 07/21/2011 | US20110177089 Apoptosis inducer |
| 07/21/2011 | US20110177074 Compositions and methods for inhibiting pdgfrbeta and vegf-a |
| 07/21/2011 | US20110177047 Methods and compositions for preventing or treating ophthalmic conditions |
| 07/21/2011 | US20110177046 Dithiazolidine and thiazolidine derivatives as anticancer agents |
| 07/21/2011 | US20110177009 Drug carrier providing mri contrast enhancement |
| 07/21/2011 | CA2804128A1 Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring |
| 07/21/2011 | CA2799474A1 Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
| 07/21/2011 | CA2791445A1 2,5,7-substituted oxazolopyrimidine derivatives |
| 07/21/2011 | CA2786537A1 5-oxo-5, 8-dihydropyrido [2, 3-d] pyrimidine derivatives as camkii kinase inhibitors for treating cardiovascular diseases |
| 07/21/2011 | CA2785970A1 Pharmaceutical for preventing or treating disorders accompanied by ocular angiogenesis and/or elevated ocular vascular permeability |
| 07/21/2011 | CA2785499A1 Isoindolinone inhibitors of phosphatidylinositol 3-kinase |
| 07/21/2011 | CA2784565A1 2,5-substituted oxazolopyrimidine derivatives |
| 07/21/2011 | CA2784560A1 Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring |
| 07/20/2011 | EP2345720A2 In vivo production of small interfering RNAs that mediate gene silencing |
| 07/20/2011 | EP2345637A2 3, 10, and 12a substituted tetracycline compounds |
| 07/20/2011 | EP2345455A1 Lacosamide for the treatment of hyperexcitability disorder and diseases associated with sodium channel dysfunction |
| 07/20/2011 | EP2345411A1 Heterocyclic aspartyl protease inhibitors, preparation and use thereof |
| 07/20/2011 | EP2344501A1 Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators |
| 07/20/2011 | EP2344494A1 Aminotriazolopyridines and their use as kinase inhibitors |
| 07/20/2011 | EP2344493A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |